Wedgewood Partners’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.3M Sell
178,034
-13,784
-7% -$1.1M 2.77% 17
2025
Q1
$14.7M Sell
191,818
-147,618
-43% -$11.3M 2.97% 16
2024
Q4
$25.1M Sell
339,436
-19,821
-6% -$1.47M 4.95% 13
2024
Q3
$23.9M Buy
359,257
+4,830
+1% +$321K 4.34% 13
2024
Q2
$23.2M Buy
354,427
+108,976
+44% +$7.14M 4.74% 12
2024
Q1
$22.1M Sell
245,451
-5,201
-2% -$469K 4.43% 13
2023
Q4
$21.6M Buy
250,652
+56,855
+29% +$4.9M 4.55% 14
2023
Q3
$13.4M Sell
193,797
-121,376
-39% -$8.41M 3.21% 14
2023
Q2
$29.7M Sell
315,173
-14,897
-5% -$1.41M 4.79% 13
2023
Q1
$27.3M Sell
330,070
-3,690
-1% -$305K 4.63% 12
2022
Q4
$24.9M Buy
333,760
+2,133
+0.6% +$159K 4.57% 9
2022
Q3
$27.4M Sell
331,627
-9,062
-3% -$749K 5.16% 9
2022
Q2
$32.4M Sell
340,689
-17,531
-5% -$1.67M 5.6% 8
2022
Q1
$42.2M Buy
358,220
+5,071
+1% +$597K 5.95% 7
2021
Q4
$45.7M Sell
353,149
-119,478
-25% -$15.5M 6.07% 5
2021
Q3
$53.5M Sell
472,627
-10,909
-2% -$1.24M 7.55% 1
2021
Q2
$50.1M Sell
483,536
-30,352
-6% -$3.14M 7.26% 4
2021
Q1
$43M Sell
513,888
-81,068
-14% -$6.78M 6.62% 4
2020
Q4
$54.3M Sell
594,956
-36,762
-6% -$3.35M 8.07% 2
2020
Q3
$50.4M Sell
631,718
-36,824
-6% -$2.94M 7.97% 2
2020
Q2
$46.2M Sell
668,542
-43,058
-6% -$2.98M 7.83% 4
2020
Q1
$44.7M Sell
711,600
-410,586
-37% -$25.8M 8.48% 2
2019
Q4
$87.3M Sell
1,122,186
-314,181
-22% -$24.4M 8.85% 2
2019
Q3
$105M Sell
1,436,367
-124,512
-8% -$9.13M 9.33% 2
2019
Q2
$96.1M Sell
1,560,879
-421,578
-21% -$26M 8.14% 4
2019
Q1
$126M Sell
1,982,457
-480,939
-20% -$30.7M 9.23% 1
2018
Q4
$126M Buy
2,463,396
+6,516
+0.3% +$333K 8.35% 3
2018
Q3
$143M Sell
2,456,880
-217,350
-8% -$12.6M 7.15% 4
2018
Q2
$130M Sell
2,674,230
-722,793
-21% -$35.1M 6.55% 5
2018
Q1
$158M Sell
3,397,023
-622,263
-15% -$28.9M 7.27% 3
2017
Q4
$151M Sell
4,019,286
-9,855
-0.2% -$370K 6.11% 6
2017
Q3
$147M Buy
4,029,141
+1,445,097
+56% +$52.7M 5.01% 11
2017
Q2
$102M Sell
2,584,044
-827,172
-24% -$32.6M 3.12% 20
2017
Q1
$107M Buy
+3,411,216
New +$107M 2.75% 19